Catalysts in Science

How unmet patient needs are shaping the next phase of cancer research

Oncology leaders Jackson Egen of Gilead Sciences and Priti Hegde of Kite, a Gilead company, discuss how unmet patient needs are shaping the next phase of cancer research. They explore how Gilead and Kite are approaching oncology across multiple fronts, drawing on advances in blood cancers and applying those lessons to solid tumors such as glioblastoma, alongside continued progress in cell therapy and other biology‑driven therapeutic approaches. Moderated by Jesse McQuarters. Read more: https://www.statnews.com/sponsor/2026/04/16/how-unmet-patient-needs-are-shaping-the-next-phase-of-cancer-research/ [https://www.statnews.com/sponsor/2026/04/16/how-unmet-patient-needs-are-shaping-the-next-phase-of-cancer-research/] Image credit: Radhika Patnala/Endosymbiont GmBH [https://www.endosymbiont.com/]

Could U.S. policy clinch China’s grip on biotech?

Drug pricing reforms were meant to protect patients — but they may also be reshaping where innovation happens. In this interview, John Stanford of Incubate explains how MFN price controls and regulatory uncertainty ripple through the biotech ecosystem, squeezing small innovators and pushing investment abroad. Moderated by Terzel Vasquez, Producer, STAT Brand Studio. Read more: https://www.statnews.com/sponsor/2026/03/04/could-u-s-policy-clinch-chinas-grip-on-biotech/

Astellas CEO talks transformative medicines driving growth

At the 2026 JPM Conference in San Francisco, Astellas President and CEO Naoki Okamura spoke with STAT Brand Studio Editor Jesse McQuarters about the company’s strategy and long-term vision as it enters an important phase in the company’s evolution. Astellas is taking a patient-centered approach and investing in four key areas within R&D — targeted protein degradation, immuno-oncology, blindness and regeneration, and genetic regulation — as it prepares for the loss of exclusivity of its leading prostate cancer therapy. Read more here: https://www.statnews.com/sponsor/2026/02/23/astellas-ceo-talks-transformative-medicines-driving-growth/

Bridging gaps in asthma care

People living with asthma understand that their environment affects their health, but they’re often left without the tools, guidance, or support to fully act on that knowledge. In this virtual event, Chiesi unveils findings from its recent Asthma Community Survey, which looks at this fundamental gap and potential solutions. In particular, this conversation explores how embedding Environmental Health Literacy (EHL) into clinical, community, and digital systems can help individuals navigate air quality improvements with greater confidence, and panelists lay out a roadmap for building more responsive, patient-centered asthma care. • Anju T. Peters, M.D. M.SCI, Professor of Medicine, Director of Clinical Research, Division of Allergy and Immunology, Director, Center for Clinical Research, Northwestern University Clinical and Translational, Sciences Institute (NUCATS), Medical Director, Northwestern Medicine Clinical Research Unit, Northwestern University Feinberg School of Medicine • Cindy Trubisky, M.Ed., AE-C, Senior Director, Nationwide Health Promotions, Asthma Programs, American Lung Association • Jesse McQuarters, Editor, STAT Brand Studio Read more: https://www.statnews.com/sponsor/2025/12/01/do-enough-allergists-and-pcps-know-about-environmental-health-literacy/

How proteomics and multi-omics are deepening our understanding of human health

In this collaborative episode of The Nucleus, Dr. John Overton, vice president and chief sequencing officer at Regeneron Genetics Center [https://www.regeneron.com/science/genetics-center] (RGC), joins STAT Brand Studio [https://sbs.statnews.com/]’s Jesse McQuarters to explore how integrating proteomics and multi-omics can deliver deeper insight into how diseases develop — and how science can better predict and prevent them.